UNH Stock Price Slips Despite Q2 Beat

UnitedHealth Group (UNH) recently reported its Q2 2026 results, beating revenue and adjusted EPS forecasts. The company also raised its full-year earnings guidance due to lower medical costs.

The stock has cooled over the past month, with a 30-day share price return of down 5.48%, but it still shows positive momentum with a year-to-date share price return of 20.57% and a one-year total shareholder return of 53.21%. However, its long-term 3- and 5-year total shareholder returns are more muted.

The company's Optum division is seen as the quiet engine behind UnitedHealth Group, with future margins and cash generation tied to how this data-driven platform scales and monetizes.